Can a common ADHD drug tame impulsive behavior? new study investigates

NCT ID NCT05278104

Completed Symptom relief Sponsor: Boehringer Ingelheim Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether atomoxetine, a medication for ADHD, can reduce impulsive behavior in adults aged 18-45 with moderate ADHD. Researchers measured impulsivity using questionnaires after a single dose and after two weeks of daily treatment. The goal was to see if the drug improves impulse control beyond a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION DEFICIT HYPERACTIVITY DISORDER

Contacts and locations

Show contact details

Locations

Rheinhessen-Fachklinik Alzey

Alzey, 55232, Germany
Universitätsklinikum Aachen, AöR

Aachen, 52074, Germany
Universitätsklinikum Bonn AöR

Bonn, 53127, Germany
Universitätsklinikum Frankfurt

Frankfurt, 60528, Germany
Universitätsklinikum Leipzig

Leipzig, 04103, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.